Even though no favorable results were obtained, more promising results have been reported regarding ALD1910, a monoclonal antibody 4000-fold more selective for PACAP38 and PACAP27 than VIP, in an umbellulone-induced rat model of headache [132]. Here, VIP is linked to Headache.